Viamet   Report issue

For profit Phase 2
Founded: Morrisville NC United States (2005)
Status: Acquired by Selenity Therapeutics (2018)

Organization Overview

First Clinical Trial
2013
NCT01891331
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree